Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Kidneys and Liver in the Elimination of Glucagon An Evaluation of the Metabolic Clearance Rate of Glucagon in Patients With End-stage Renal Disease and Patients With Liver Cirrhosis

NCT05056584 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.

NCT NCT05056584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Kidneys and Liver in the Elimination of Glucagon An Evaluation of the Metabolic Clearance Rate of Glucagon in Patients With End-stage Renal Disease and Patients With Liver Cirrhosis
Lead sponsor
University Hospital, Gentofte, Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2020
Completion date
March 28, 2023
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, hyperglucagonemia, liver cirrhosis